Eli Lilly’s ticker is LLY, and its drug Mounjaro contains tirzepatide.
Eli Lilly and Company was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist and Union army veteran. The company is headquartered in Indianapolis, Indiana, and has developed medicines across diabetes, oncology, immunology, neuroscience, and other fields.
Mounjaro is the brand name for tirzepatide when prescribed for type 2 diabetes in the United States. Tirzepatide is also marketed as Zepbound for chronic weight management in eligible patients. The two products contain the same active ingredient but have different approved uses and branding.
The stock ticker LLY is used on the New York Stock Exchange. A company’s market capitalization reflects the market value of its shares and can rise or fall with expectations about drug demand, clinical results, competition, and regulation.